Is renal stenting dead post-CORAL? Should we intervene more in PAD after ERASE? Drs. Bilazarian and Creager discuss these peripheral trials from AHA 2013.

Dr. Jeffrey Berns explains why recent guidelines discouraging kidney screening have been so controversial in the nephrology community.

New technology reveals that many herbal products on the market contain different ingredients from those listed on their labels, reports Dr. Gerald Chodak.

FDA Commissioner Margaret Hamburg, MD, talks with Medscape at the National Health Research Forum in Washington, DC.

Dr. Clifford Bailey explains how the mechanism of action differs with the new 'flozin' drugs for type 2 diabetes, and where they fit in the overall armamentarium for this disease.

American Psychiatric Association President Dr. Jeffrey Lieberman on how government policies are out of sync with our country's medical needs.

People share the most private moments on social media, even when someone is at death's door. Is this an invasion of privacy?

The landmark UK Prospective Diabetes Study completely changed the way clinicians view diabetes management, recalls Dr. David Matthews.